Fl
Flare Ther
Cambridge MAFounded 202045 employees
Private CapbiotechPrivateRare DiseaseNeurology
Platform: Gene Reg
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zoritenlimab | FLA-6916 | Preclinical | 1 | CDK4/6 | ADPKDHNSCC | ||
| Olparelsin | FLA-7827 | Preclinical | 1 | FcRn | CRCMS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (2)